CVS Pharmacy Closed in Radford, VA

Radford, VA, February 2nd, 2026 – Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research, and advisory services, announced today the sale of a CVS Pharmacy, a 11,970-square-foot property located at 31 West Main Street, Radford, VA, according to Tim Stephenson, regional manager of the firm’s Philadelphia office. The asset sold for $1,840,000.

Jacob Haslach and Derrick Dougherty, investment specialists in Marcus & Millichap’s Philadelphia office, had the exclusive listing to market the property on behalf of the seller, a New York–based family. Jacob Haslach and Derrick Dougherty had the opportunity to represent the buyer, a Florida-based private investor, in this transaction.

“This asset offered exceptional real estate fundamentals, including a 1.9-acre site with nearly 70 parking spaces adjacent to Radford University,” said Jacob Haslach, Associate Investments. “CVS has operated at this location for over 17 years, demonstrating a strong, long-term commitment to the site.”

“The buyer acquired a high-quality, fully maintained asset featuring a true NNN ground lease with more than seven years remaining,” Haslach added. “It was a pleasure working collaboratively with all parties to successfully close this transaction.”

_____________________________________________________________________________________________

 

About Marcus & Millichap, Inc. (NYSE: MMI) 

 

Marcus & Millichap, Inc. is a leading national brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. Marcus & Millichap closed 7,836 transactions in 2024, with a sales volume of approximately $49.6 billion in 2024. The company had 1,712 investment sales and financing professionals in more than 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate at year end. For additional information, please visit www.MarcusMillichap.com.